Virgin Islands (U.S.)
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.43 (0.37 - 0.50) | 2019 | Modelled | IHME |
| 0.43 (0.37 - 0.50) | 2018 | Modelled | IHME |
| 0.44 (0.37 - 0.51) | 2017 | Modelled | IHME |
| 0.44 (0.37 - 0.50) | 2016 | Modelled | IHME |
| 0.44 (0.37 - 0.51) | 2015 | Modelled | IHME |
| 0.44 (0.37 - 0.51) | 2014 | Modelled | IHME |
| 0.45 (0.38 - 0.52) | 2013 | Modelled | IHME |
| 0.45 (0.38 - 0.53) | 2012 | Modelled | IHME |
| 0.46 (0.38 - 0.53) | 2011 | Modelled | IHME |
| 0.47 (0.38 - 0.54) | 2010 | Modelled | IHME |
| 0.47 (0.39 - 0.55) | 2009 | Modelled | IHME |
| 0.48 (0.40 - 0.55) | 2008 | Modelled | IHME |
| 0.49 (0.41 - 0.56) | 2007 | Modelled | IHME |
| 0.5 (0.42 - 0.57) | 2006 | Modelled | IHME |
| 0.5 (0.42 - 0.58) | 2005 | Modelled | IHME |
| 0.51 (0.43 - 0.58) | 2004 | Modelled | IHME |
| 0.51 (0.43 - 0.59) | 2003 | Modelled | IHME |
| 0.51 (0.43 - 0.59) | 2002 | Modelled | IHME |
| 0.52 (0.43 - 0.60) | 2001 | Modelled | IHME |
| 0.52 (0.43 - 0.61) | 2000 | Modelled | IHME |
| 0.53 (0.43 - 0.61) | 1999 | Modelled | IHME |
| 0.53 (0.44 - 0.62) | 1998 | Modelled | IHME |
| 0.54 (0.45 - 0.62) | 1997 | Modelled | IHME |
| 0.55 (0.46 - 0.64) | 1996 | Modelled | IHME |
| 0.56 (0.46 - 0.65) | 1995 | Modelled | IHME |
| 0.56 (0.47 - 0.65) | 1994 | Modelled | IHME |
| 0.57 (0.47 - 0.66) | 1993 | Modelled | IHME |
| 0.57 (0.47 - 0.67) | 1992 | Modelled | IHME |
| 0.58 (0.47 - 0.68) | 1991 | Modelled | IHME |
| 0.58 (0.47 - 0.69) | 1990 | Modelled | IHME |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.1 (0.07 - 0.13) | 2019 | Modelled | IHME |
| 0.1 (0.07 - 0.13) | 2018 | Modelled | IHME |
| 0.1 (0.07 - 0.14) | 2017 | Modelled | IHME |
| 0.1 (0.07 - 0.13) | 2016 | Modelled | IHME |
| 0.09 (0.06 - 0.13) | 2015 | Modelled | IHME |
| 0.09 (0.06 - 0.12) | 2014 | Modelled | IHME |
| 0.09 (0.06 - 0.12) | 2013 | Modelled | IHME |
| 0.08 (0.06 - 0.11) | 2012 | Modelled | IHME |
| 0.08 (0.05 - 0.11) | 2011 | Modelled | IHME |
| 0.08 (0.05 - 0.11) | 2010 | Modelled | IHME |
| 0.08 (0.05 - 0.10) | 2009 | Modelled | IHME |
| 0.07 (0.05 - 0.10) | 2008 | Modelled | IHME |
| 0.07 (0.05 - 0.09) | 2007 | Modelled | IHME |
| 0.07 (0.05 - 0.09) | 2006 | Modelled | IHME |
| 0.07 (0.05 - 0.09) | 2005 | Modelled | IHME |
| 0.07 (0.05 - 0.09) | 2004 | Modelled | IHME |
| 0.07 (0.05 - 0.10) | 2003 | Modelled | IHME |
| 0.08 (0.05 - 0.10) | 2002 | Modelled | IHME |
| 0.08 (0.06 - 0.11) | 2001 | Modelled | IHME |
| 0.09 (0.06 - 0.12) | 2000 | Modelled | IHME |
| 0.09 (0.06 - 0.13) | 1999 | Modelled | IHME |
| 0.1 (0.07 - 0.13) | 1998 | Modelled | IHME |
| 0.11 (0.07 - 0.14) | 1997 | Modelled | IHME |
| 0.11 (0.08 - 0.16) | 1996 | Modelled | IHME |
| 0.12 (0.08 - 0.17) | 1995 | Modelled | IHME |
| 0.13 (0.09 - 0.18) | 1994 | Modelled | IHME |
| 0.14 (0.10 - 0.19) | 1993 | Modelled | IHME |
| 0.15 (0.11 - 0.21) | 1992 | Modelled | IHME |
| 0.16 (0.11 - 0.22) | 1991 | Modelled | IHME |
| 0.17 (0.12 - 0.24) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.39 (2.43 - 4.57) | 2019 | Modelled | IHME |
| 3.35 (2.41 - 4.53) | 2018 | Modelled | IHME |
| 3.32 (2.40 - 4.45) | 2017 | Modelled | IHME |
| 3.28 (2.36 - 4.34) | 2016 | Modelled | IHME |
| 3.26 (2.37 - 4.35) | 2015 | Modelled | IHME |
| 3.22 (2.36 - 4.32) | 2014 | Modelled | IHME |
| 3.2 (2.36 - 4.25) | 2013 | Modelled | IHME |
| 3.19 (2.35 - 4.27) | 2012 | Modelled | IHME |
| 3.16 (2.33 - 4.26) | 2011 | Modelled | IHME |
| 3.13 (2.33 - 4.22) | 2010 | Modelled | IHME |
| 3.1 (2.31 - 4.16) | 2009 | Modelled | IHME |
| 3.08 (2.28 - 4.12) | 2008 | Modelled | IHME |
| 3.07 (2.28 - 4.11) | 2007 | Modelled | IHME |
| 2.54 (1.92 - 3.33) | 2006 | Modelled | IHME |
| 2.48 (1.87 - 3.26) | 2005 | Modelled | IHME |
| 2.51 (1.88 - 3.28) | 2004 | Modelled | IHME |
| 2.53 (1.90 - 3.30) | 2003 | Modelled | IHME |
| 2.57 (1.93 - 3.36) | 2002 | Modelled | IHME |
| 2.62 (1.99 - 3.46) | 2001 | Modelled | IHME |
| 2.67 (1.99 - 3.51) | 2000 | Modelled | IHME |
| 2.8 (2.10 - 3.66) | 1999 | Modelled | IHME |
| 2.89 (2.14 - 3.81) | 1998 | Modelled | IHME |
| 3.02 (2.26 - 3.97) | 1997 | Modelled | IHME |
| 3.21 (2.39 - 4.20) | 1996 | Modelled | IHME |
| 3.32 (2.51 - 4.36) | 1995 | Modelled | IHME |
| 3.44 (2.61 - 4.53) | 1994 | Modelled | IHME |
| 3.4 (2.55 - 4.50) | 1993 | Modelled | IHME |
| 3.37 (2.55 - 4.49) | 1992 | Modelled | IHME |
| 3.37 (2.52 - 4.46) | 1991 | Modelled | IHME |
| 3.41 (2.54 - 4.55) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 4 (3 - 5) | 2019 | Modelled | IHME |
| 4 (3 - 5) | 2018 | Modelled | IHME |
| 3 (3 - 5) | 2017 | Modelled | IHME |
| 3 (2 - 5) | 2016 | Modelled | IHME |
| 3 (3 - 5) | 2015 | Modelled | IHME |
| 3 (3 - 5) | 2014 | Modelled | IHME |
| 3 (3 - 5) | 2013 | Modelled | IHME |
| 3 (3 - 5) | 2012 | Modelled | IHME |
| 3 (3 - 5) | 2011 | Modelled | IHME |
| 3 (3 - 5) | 2010 | Modelled | IHME |
| 3 (3 - 5) | 2009 | Modelled | IHME |
| 3 (3 - 5) | 2008 | Modelled | IHME |
| 3 (3 - 5) | 2007 | Modelled | IHME |
| 3 (2 - 4) | 2006 | Modelled | IHME |
| 3 (2 - 4) | 2005 | Modelled | IHME |
| 3 (2 - 4) | 2004 | Modelled | IHME |
| 3 (2 - 4) | 2003 | Modelled | IHME |
| 3 (2 - 4) | 2002 | Modelled | IHME |
| 3 (2 - 4) | 2001 | Modelled | IHME |
| 3 (2 - 4) | 2000 | Modelled | IHME |
| 3 (2 - 4) | 1999 | Modelled | IHME |
| 3 (2 - 4) | 1998 | Modelled | IHME |
| 3 (2 - 4) | 1997 | Modelled | IHME |
| 4 (3 - 5) | 1996 | Modelled | IHME |
| 4 (3 - 5) | 1995 | Modelled | IHME |
| 4 (3 - 5) | 1994 | Modelled | IHME |
| 4 (3 - 5) | 1993 | Modelled | IHME |
| 4 (3 - 5) | 1992 | Modelled | IHME |
| 4 (3 - 5) | 1991 | Modelled | IHME |
| 4 (3 - 5) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 24 (17 - 33) | 2019 | Modelled | IHME |
| 25 (17 - 34) | 2018 | Modelled | IHME |
| 25 (17 - 34) | 2017 | Modelled | IHME |
| 25 (18 - 34) | 2016 | Modelled | IHME |
| 25 (18 - 34) | 2015 | Modelled | IHME |
| 25 (18 - 35) | 2014 | Modelled | IHME |
| 25 (18 - 35) | 2013 | Modelled | IHME |
| 26 (19 - 35) | 2012 | Modelled | IHME |
| 26 (19 - 35) | 2011 | Modelled | IHME |
| 26 (19 - 36) | 2010 | Modelled | IHME |
| 27 (19 - 36) | 2009 | Modelled | IHME |
| 27 (19 - 36) | 2008 | Modelled | IHME |
| 27 (20 - 36) | 2007 | Modelled | IHME |
| 27 (20 - 36) | 2006 | Modelled | IHME |
| 27 (20 - 36) | 2005 | Modelled | IHME |
| 27 (20 - 36) | 2004 | Modelled | IHME |
| 27 (20 - 36) | 2003 | Modelled | IHME |
| 27 (20 - 36) | 2002 | Modelled | IHME |
| 28 (21 - 37) | 2001 | Modelled | IHME |
| 28 (21 - 37) | 2000 | Modelled | IHME |
| 28 (21 - 37) | 1999 | Modelled | IHME |
| 28 (21 - 37) | 1998 | Modelled | IHME |
| 29 (22 - 37) | 1997 | Modelled | IHME |
| 29 (22 - 37) | 1996 | Modelled | IHME |
| 29 (22 - 38) | 1995 | Modelled | IHME |
| 29 (22 - 38) | 1994 | Modelled | IHME |
| 30 (22 - 38) | 1993 | Modelled | IHME |
| 30 (22 - 39) | 1992 | Modelled | IHME |
| 30 (23 - 39) | 1991 | Modelled | IHME |
| 30 (23 - 39) | 1990 | Modelled | IHME |
Showing out of
Show more
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.06 (1.68 - 2.54) | 2019 | Modelled | IHME |
| 2.05 (1.68 - 2.52) | 2018 | Modelled | IHME |
| 2.03 (1.67 - 2.52) | 2017 | Modelled | IHME |
| 2 (1.65 - 2.47) | 2016 | Modelled | IHME |
| 1.98 (1.61 - 2.44) | 2015 | Modelled | IHME |
| 1.96 (1.60 - 2.42) | 2014 | Modelled | IHME |
| 1.96 (1.60 - 2.41) | 2013 | Modelled | IHME |
| 1.95 (1.59 - 2.41) | 2012 | Modelled | IHME |
| 1.94 (1.59 - 2.41) | 2011 | Modelled | IHME |
| 1.94 (1.58 - 2.41) | 2010 | Modelled | IHME |
| 1.94 (1.59 - 2.40) | 2009 | Modelled | IHME |
| 1.94 (1.59 - 2.39) | 2008 | Modelled | IHME |
| 1.93 (1.58 - 2.39) | 2007 | Modelled | IHME |
| 1.93 (1.58 - 2.40) | 2006 | Modelled | IHME |
| 1.93 (1.57 - 2.41) | 2005 | Modelled | IHME |
| 1.93 (1.57 - 2.40) | 2004 | Modelled | IHME |
| 1.92 (1.57 - 2.37) | 2003 | Modelled | IHME |
| 1.91 (1.55 - 2.36) | 2002 | Modelled | IHME |
| 1.9 (1.55 - 2.36) | 2001 | Modelled | IHME |
| 1.89 (1.53 - 2.35) | 2000 | Modelled | IHME |
| 1.88 (1.53 - 2.34) | 1999 | Modelled | IHME |
| 1.87 (1.52 - 2.32) | 1998 | Modelled | IHME |
| 1.87 (1.51 - 2.32) | 1997 | Modelled | IHME |
| 1.86 (1.51 - 2.32) | 1996 | Modelled | IHME |
| 1.85 (1.50 - 2.32) | 1995 | Modelled | IHME |
| 1.85 (1.50 - 2.32) | 1994 | Modelled | IHME |
| 1.85 (1.50 - 2.31) | 1993 | Modelled | IHME |
| 1.84 (1.49 - 2.32) | 1992 | Modelled | IHME |
| 1.84 (1.49 - 2.32) | 1991 | Modelled | IHME |
| 1.84 (1.47 - 2.31) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 6.63 (4.58 - 9.19) | 2019 | Modelled | IHME |
| 6.59 (4.57 - 9.23) | 2018 | Modelled | IHME |
| 6.53 (4.55 - 9.10) | 2017 | Modelled | IHME |
| 6.46 (4.50 - 8.96) | 2016 | Modelled | IHME |
| 6.44 (4.53 - 8.99) | 2015 | Modelled | IHME |
| 6.36 (4.54 - 8.78) | 2014 | Modelled | IHME |
| 6.28 (4.53 - 8.66) | 2013 | Modelled | IHME |
| 6.2 (4.50 - 8.48) | 2012 | Modelled | IHME |
| 6.08 (4.43 - 8.34) | 2011 | Modelled | IHME |
| 5.98 (4.37 - 8.21) | 2010 | Modelled | IHME |
| 5.86 (4.31 - 8.03) | 2009 | Modelled | IHME |
| 5.77 (4.28 - 7.94) | 2008 | Modelled | IHME |
| 5.71 (4.22 - 7.82) | 2007 | Modelled | IHME |
| 4.76 (3.57 - 6.44) | 2006 | Modelled | IHME |
| 4.59 (3.42 - 6.15) | 2005 | Modelled | IHME |
| 4.56 (3.40 - 6.12) | 2004 | Modelled | IHME |
| 4.51 (3.34 - 6.04) | 2003 | Modelled | IHME |
| 4.46 (3.32 - 5.93) | 2002 | Modelled | IHME |
| 4.44 (3.26 - 5.91) | 2001 | Modelled | IHME |
| 4.4 (3.26 - 5.83) | 2000 | Modelled | IHME |
| 4.47 (3.32 - 5.89) | 1999 | Modelled | IHME |
| 4.45 (3.32 - 5.84) | 1998 | Modelled | IHME |
| 4.49 (3.40 - 5.85) | 1997 | Modelled | IHME |
| 4.59 (3.48 - 6) | 1996 | Modelled | IHME |
| 4.61 (3.47 - 6.06) | 1995 | Modelled | IHME |
| 4.68 (3.51 - 6.19) | 1994 | Modelled | IHME |
| 4.53 (3.37 - 6.03) | 1993 | Modelled | IHME |
| 4.43 (3.29 - 5.89) | 1992 | Modelled | IHME |
| 4.35 (3.21 - 5.78) | 1991 | Modelled | IHME |
| 4.33 (3.19 - 5.79) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 7 (5 - 10) | 2019 | Modelled | IHME |
| 7 (5 - 10) | 2018 | Modelled | IHME |
| 7 (5 - 10) | 2017 | Modelled | IHME |
| 7 (5 - 9) | 2016 | Modelled | IHME |
| 7 (5 - 10) | 2015 | Modelled | IHME |
| 7 (5 - 9) | 2014 | Modelled | IHME |
| 7 (5 - 9) | 2013 | Modelled | IHME |
| 7 (5 - 9) | 2012 | Modelled | IHME |
| 7 (5 - 9) | 2011 | Modelled | IHME |
| 6 (5 - 9) | 2010 | Modelled | IHME |
| 6 (5 - 9) | 2009 | Modelled | IHME |
| 6 (5 - 9) | 2008 | Modelled | IHME |
| 6 (5 - 9) | 2007 | Modelled | IHME |
| 5 (4 - 7) | 2006 | Modelled | IHME |
| 5 (4 - 7) | 2005 | Modelled | IHME |
| 5 (4 - 7) | 2004 | Modelled | IHME |
| 5 (4 - 7) | 2003 | Modelled | IHME |
| 5 (4 - 7) | 2002 | Modelled | IHME |
| 5 (4 - 7) | 2001 | Modelled | IHME |
| 5 (4 - 6) | 2000 | Modelled | IHME |
| 5 (4 - 7) | 1999 | Modelled | IHME |
| 5 (4 - 6) | 1998 | Modelled | IHME |
| 5 (4 - 6) | 1997 | Modelled | IHME |
| 5 (4 - 7) | 1996 | Modelled | IHME |
| 5 (4 - 7) | 1995 | Modelled | IHME |
| 5 (4 - 7) | 1994 | Modelled | IHME |
| 5 (4 - 6) | 1993 | Modelled | IHME |
| 5 (4 - 6) | 1992 | Modelled | IHME |
| 5 (3 - 6) | 1991 | Modelled | IHME |
| 5 (3 - 6) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 22 (15 - 30) | 2019 | Modelled | IHME |
| 22 (15 - 29) | 2018 | Modelled | IHME |
| 22 (15 - 29) | 2017 | Modelled | IHME |
| 21 (14 - 29) | 2016 | Modelled | IHME |
| 21 (14 - 29) | 2015 | Modelled | IHME |
| 21 (14 - 29) | 2014 | Modelled | IHME |
| 21 (14 - 29) | 2013 | Modelled | IHME |
| 21 (14 - 29) | 2012 | Modelled | IHME |
| 21 (15 - 29) | 2011 | Modelled | IHME |
| 21 (14 - 29) | 2010 | Modelled | IHME |
| 21 (14 - 29) | 2009 | Modelled | IHME |
| 21 (14 - 29) | 2008 | Modelled | IHME |
| 21 (14 - 29) | 2007 | Modelled | IHME |
| 22 (15 - 30) | 2006 | Modelled | IHME |
| 23 (16 - 30) | 2005 | Modelled | IHME |
| 22 (16 - 30) | 2004 | Modelled | IHME |
| 22 (15 - 30) | 2003 | Modelled | IHME |
| 22 (16 - 30) | 2002 | Modelled | IHME |
| 22 (16 - 30) | 2001 | Modelled | IHME |
| 22 (16 - 30) | 2000 | Modelled | IHME |
| 22 (16 - 30) | 1999 | Modelled | IHME |
| 22 (16 - 30) | 1998 | Modelled | IHME |
| 22 (16 - 30) | 1997 | Modelled | IHME |
| 22 (15 - 29) | 1996 | Modelled | IHME |
| 22 (16 - 29) | 1995 | Modelled | IHME |
| 22 (15 - 29) | 1994 | Modelled | IHME |
| 22 (16 - 29) | 1993 | Modelled | IHME |
| 22 (16 - 29) | 1992 | Modelled | IHME |
| 22 (15 - 29) | 1991 | Modelled | IHME |
| 22 (15 - 29) | 1990 | Modelled | IHME |
Showing out of
Show more
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Overview
Prevalence (national)
Modelled
HBV (HBsAg+)
0.43
(%)
2019
(0.37 - 0.5(%))
IHME
HCV (RNA/cAg+)
2.06
(%)
2019
(1.68 - 2.54(%))
IHME
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
4
2019
(3 - 5)
IHME
Survey/surveillance
No data available
HBV chart
Modelled
HCV
7
2019
(5 - 10)
IHME
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
0.10
(%)
2019, latest modelled
(0.07 - 0.13(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines